Jae H Kang1, Kerry L Ivey2,3, Tahani Boumenna4, Bernard Rosner1,5, Janey L Wiggs4, Louis R Pasquale1,4. 1. Channing Division of Network Medicine, Department of Medicine, Brigham & Women's Hospital/Harvard Medical School, Boston, MA, USA. 2. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA. 3. South Australian Health and Medical Research Institute, Infection and Immunity Theme, School of Medicine, Flinders University, Adelaide, SA, Australia. 4. Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, MA, USA. 5. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Abstract
PURPOSE: To evaluate the association between flavonoid intake and incident primary open-angle glaucoma (POAG). METHODS: We followed 65 516 women from the Nurses' Health Study (from 1984) and 42 156 men from the Health Professionals Follow-up Study (from 1986) biennially to 2012, who were 40+ years old, free of POAG, and reported eye examinations. Dietary flavonoid intake was assessed with validated repeated semi-quantitative food frequency questionnaires. Incident POAG cases (n = 1575) were confirmed with medical record review. Cohort-specific multivariable-adjusted relative risks (RRs) and 95% confidence intervals (CIs) were calculated and meta-analysed. RESULTS: Total flavonoid intake was not associated with risk of POAG development [RR for highest (Q5: median ~645 mg/day) versus lowest quintile (Q1: ~130 mg/day) = 0.91 (95% CI = 0.77, 1.08); p for trend (p-trend) = 0.19]; the flavonoid subclasses of flavones, flavanones, polymeric flavanols or anthocyanidins were also not associated (Q5 versus Q1 comparison p-values ≥0.05 and p-trend ≥0.09). Higher intakes of flavonols and monomeric flavanols were nominally associated with lower POAG risk, based on the Q5 versus Q1 comparisons or p-trends. The Q5 versus Q1 comparison RRs were: for flavonols, 0.82 (95% CI = 0.69, 0.97; p-trend = 0.05; ~28 versus ~8 mg/day), and for monomeric flavanols, 0.86 (95% CI = 0.72, 1.02; p-trend=0.04; ~110 versus 10 mg/day). The food/beverage that contributed most to both the variation of flavonols and monomeric flavanols was tea; consuming ~2 cups/day was associated with 18% lower POAG risk (RR=0.82; 95% CI = 0.68, 0.99; p-trend = 0.02). CONCLUSION: Total flavonoid intake was not associated with POAG risk. Greater intakes of flavonols and monomeric flavanols and of tea showed suggestive modest associations with lower risk; these results need confirmation.
PURPOSE: To evaluate the association between flavonoid intake and incident primary open-angle glaucoma (POAG). METHODS: We followed 65 516 women from the Nurses' Health Study (from 1984) and 42 156 men from the Health Professionals Follow-up Study (from 1986) biennially to 2012, who were 40+ years old, free of POAG, and reported eye examinations. Dietary flavonoid intake was assessed with validated repeated semi-quantitative food frequency questionnaires. Incident POAG cases (n = 1575) were confirmed with medical record review. Cohort-specific multivariable-adjusted relative risks (RRs) and 95% confidence intervals (CIs) were calculated and meta-analysed. RESULTS: Total flavonoid intake was not associated with risk of POAG development [RR for highest (Q5: median ~645 mg/day) versus lowest quintile (Q1: ~130 mg/day) = 0.91 (95% CI = 0.77, 1.08); p for trend (p-trend) = 0.19]; the flavonoid subclasses of flavones, flavanones, polymeric flavanols or anthocyanidins were also not associated (Q5 versus Q1 comparison p-values ≥0.05 and p-trend ≥0.09). Higher intakes of flavonols and monomeric flavanols were nominally associated with lower POAG risk, based on the Q5 versus Q1 comparisons or p-trends. The Q5 versus Q1 comparison RRs were: for flavonols, 0.82 (95% CI = 0.69, 0.97; p-trend = 0.05; ~28 versus ~8 mg/day), and for monomeric flavanols, 0.86 (95% CI = 0.72, 1.02; p-trend=0.04; ~110 versus 10 mg/day). The food/beverage that contributed most to both the variation of flavonols and monomeric flavanols was tea; consuming ~2 cups/day was associated with 18% lower POAG risk (RR=0.82; 95% CI = 0.68, 0.99; p-trend = 0.02). CONCLUSION: Total flavonoid intake was not associated with POAG risk. Greater intakes of flavonols and monomeric flavanols and of tea showed suggestive modest associations with lower risk; these results need confirmation.
Authors: Kai On Chu; Kwok Ping Chan; Chi Chiu Wang; Ching Yan Chu; Wai Ying Li; Kwong Wai Choy; Michael Scott Rogers; Chi Pui Pang Journal: J Agric Food Chem Date: 2010-02-10 Impact factor: 5.279
Authors: F B Hu; M J Stampfer; J E Manson; E Rimm; G A Colditz; B A Rosner; C H Hennekens; W C Willett Journal: N Engl J Med Date: 1997-11-20 Impact factor: 91.245
Authors: S Salvini; D J Hunter; L Sampson; M J Stampfer; G A Colditz; B Rosner; W C Willett Journal: Int J Epidemiol Date: 1989-12 Impact factor: 7.196
Authors: Jae H Kang; Tahani Boumenna; Joshua D Stein; Anthony Khawaja; Bernard A Rosner; Janey L Wiggs; Louis R Pasquale Journal: JAMA Ophthalmol Date: 2019-07-01 Impact factor: 7.389
Authors: Jae H Kang; Trang VoPham; Francine Laden; Bernard A Rosner; Barbara Wirostko; Robert Ritch; Janey L Wiggs; Abrar Qureshi; Hongmei Nan; Louis R Pasquale Journal: J Glaucoma Date: 2020-06 Impact factor: 2.503
Authors: Weiye Wang; Sayoko Moroi; Kelly Bakulski; Bhramar Mukherjee; Marc G Weisskopf; Debra Schaumberg; David Sparrow; Pantel S Vokonas; Howard Hu; Sung Kyun Park Journal: Environ Health Perspect Date: 2018-08-08 Impact factor: 9.031